MetaCap

Citius Pharmaceuticals (CTXR) News

NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5085+0.0113 (+2.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CTXR news summary

We found 1 recent headline mentioning Citius Pharmaceuticals (CTXR): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. For price context, CTXR is up 2.27% at $0.5085. The most recent story, "Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026", was published by PR Newswire on Oct 26, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Citius Pharmaceuticals headlines

Stocks mentioned alongside CTXR

Compare CTXR